VM
ALBO

VHCP Management’s Albireo Pharma Inc ALBO Stock Holding History

VHCP Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-39,883
Closed -$2.73M – 18
2013
Q4 		$2.73M Sell
39,883
-2,837
-7% -$208K 1.47% 15
2013
Q3 		$4.04M Sell
42,720
-5,494
-11% -$715K 2.23% 13
2013
Q2 		$6.05M Buy
+48,214
New +$5.02M 4.49% 9

Other funds holding ALBO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VHCP Management's ALBO Position: Q1 2014 in Review

VHCP Management sold out of Albireo Pharma Inc (ALBO) in Q1 2014, closing a stake of 39,883 shares — an estimated $2.73M sold.

VHCP Management first reported a position in ALBO in Q2 2013 and held it in 3 quarters. The position peaked at $6.05M in Q2 2013. 43 funds tracked by Wall St. Rank hold ALBO as of Q1 2014.

  • VHCP Management reported no remaining Albireo Pharma Inc position as of Q1 2014 after selling out during the quarter.
  • VHCP Management sold 39,883 Albireo Pharma Inc shares in Q1 2014, an estimated $2.73M.
  • VHCP Management first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 3 quarters.
  • VHCP Management's Albireo Pharma Inc position peaked at $6.05M in Q2 2013.
  • 43 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2014.

Based on VHCP Management's 13F filing for Q1 2014, filed 14 May 2014.